in a multicentre double-blind trial , 2500 patients with a clinical diagnosis of a recent cerebrovascular event of atherothrombotic origin ( transient ischaemic attack , reversible ischaemic neurological deficit , or stroke ) were randomised to receive either dipyridamole 75 mg plus acetylsalicylic acid 325 mg ( dp-asa , 1250 patients ) or placebo ( 1250 patients ) thrice daily .
C0007787
transient ischaemic
C0004057
asa